Search Results for: influenza

Detection of influenza and other acute respiratory viruses: haemagglutinin-specific antibodies and viral antigens for assay development and research.

Advanced ImmunoChemical offers 15 antigens of influenza and other acute respiratory diseases, as well as a selection of monoclonal antibodies for the detection of these respiratory illnesses: influenza type A and type B, respiratory syncytial virus, adenovirus, and Newcastle disease. These haemagglutinin-specific antibodies are suitable for the detection of specific strains of influenza through ELISA and Western … Read more

Influenza A (H3N2) virus (strain A/Shangdong/9/93)

[add_desc][title]Source:[/title][description]Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza A virus, strain A/Shangdong/9/93.[/description][/add_desc] [add_desc][title]Applications:[/title][description]Serological studies of influenza A virus, immunogen for antibody production.[/description][/add_desc] [add_desc][title]Analysis:[/title][description]Purity > 90 %[/description][/add_desc] [add_desc][title]Immunological activity:[/title][description]Tested with anti-influenza A monoclonal antibodies in ELISA.[/description][/add_desc] [add_desc][title]Purification:[/title][description]Ultracentrifugation with 10 – 40 % sucrose gradient.[/description][/add_desc] [add_desc][title]Presentation:[/title][description]Presentation: STE, 0.09 % sodium azide (NaN3) and 0.005 % thimerosal.[/description][/add_desc] [add_desc][title]Storage Conditions:[/title][description]-20 °C (between -15 and -30 °C allowed)[/description][/add_desc] [add_desc][title]Inactivation:[/title][description]Thimerosal and beta propiolactone treatment.
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices and techniques are required at work.[/description][/add_desc] [add_desc][title]Material safety note:[/title][description]This product is sold for research use only. Standard Laboratory Practices should be followed when handling this material.
Product contains sodium azide as a preservative. Although the amount of sodium azide is very small appropriate care must be taken when handling this product.[/description][/add_desc] [add_desc][title]Additional product information:[/title][description] Influenza and Other Acute Respiratory Diseases (ARDs) Assay Notes[/description][/add_desc] [add_desc][title]References:[/title][description] Search Influenza A (H3N2) virus references from PubMud.

See all influenza references.[/description][/add_desc] [add_desc][title]Related Products:[/title][description]See other infectious diseases and veterinary reagents.[/description][/add_desc]

Influenza B virus (strain B/Victoria-504-00)

[add_desc][title]Source:[/title][description]Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza B virus, strain B/Victoria/504/00.[/description][/add_desc] [add_desc][title]Applications:[/title][description]Serological studies of influenza B virus, immunogen for antibody production.[/description][/add_desc] [add_desc][title]Analysis:[/title][description]Purity > 90 %[/description][/add_desc] [add_desc][title]Immunological activity:[/title][description]Tested with anti-influenza B monoclonal antibodies ( Cat. # 5-IVB) in ELISA.[/description][/add_desc] [add_desc][title]Purification:[/title][description]Ultracentrifugation with 10 – 40 % sucrose gradient.[/description][/add_desc] [add_desc][title]Presentation:[/title][description]STE, 0.09 % sodium azide (NaN3) and 0.005 % thimerosal.[/description][/add_desc] [add_desc][title]Storage Conditions:[/title][description]-20 °C (between -15 and -30 °C allowed)[/description][/add_desc] [add_desc][title]Inactivation:[/title][description]Thimerosal and beta propiolactone treatment.
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices and techniques are required at work.[/description][/add_desc] [add_desc][title]Material safety note:[/title][description]This product is sold for research use only. Standard Laboratory Practices should be followed when handling this material.
Product contains sodium azide as a preservative. Although the amount of sodium azide is very small appropriate care must be taken when handling this product.[/description][/add_desc] [add_desc][title]Additional product information:[/title][description] Influenza and Other Acute Respiratory Diseases (ARDs) Assay Notes[/description][/add_desc] [add_desc][title]References:[/title][description] Search Influenza B virus-3 references from PubMud.

See all influenza references.[/description][/add_desc] [add_desc][title]Related Products:[/title][description]See other infectious diseases and veterinary reagents.[/description][/add_desc]

Influenza B virus (strain B/Malaysia/2506/04)

[add_desc][title]Source:[/title][description]Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza B virus, strain B/Malaysia/2506/04.[/description][/add_desc] [add_desc][title]Applications:[/title][description]Serological studies of influenza B virus, immunogen for antibody production.[/description][/add_desc] [add_desc][title]Analysis:[/title][description]Purity > 90 %[/description][/add_desc] [add_desc][title]Purification:[/title][description]Ultracentrifugation with 10 – 40 % sucrose gradient.[/description][/add_desc] [add_desc][title]Presentation:[/title][description]STE, 0.09 % sodium azide (NaN3) and 0.005 % thimerosal.[/description][/add_desc] [add_desc][title]Storage Conditions:[/title][description]-20 °C (between -15 and -30 °C allowed)[/description][/add_desc] [add_desc][title]Inactivation:[/title][description]Thimerosal and beta propiolactone treatment.
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices and techniques are required at work.[/description][/add_desc] [add_desc][title]Material safety note:[/title][description]This product is sold for research use only. Standard Laboratory Practices should be followed when handling this material.
Product contains sodium azide as a preservative. Although the amount of sodium azide is very small appropriate care must be taken when handling this product.[/description][/add_desc] [add_desc][title]Additional product information:[/title][description] Influenza and Other Acute Respiratory Diseases (ARDs) Assay Notes[/description][/add_desc] [add_desc][title]References:[/title][description] Search Influenza B virus-4 references from PubMud.

See all influenza references.[/description][/add_desc] [add_desc][title]Related Products:[/title][description]See other infectious diseases and veterinary reagents.[/description][/add_desc]

Influenza A (H3N2) virus (strain A/Brisbane/10/06)

[add_desc][title]Source:[/title][description]Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza A virus, strain A/Brisbane/10/07.[/description][/add_desc] [add_desc][title]Applications:[/title][description]Serological studies of influenza A virus, immunogen for antibody production.[/description][/add_desc] [add_desc][title]Analysis:[/title][description]Purity > 90 %[/description][/add_desc] [add_desc][title]Purification:[/title][description]Ultracentrifugation with 10 – 40 % sucrose gradient.[/description][/add_desc] [add_desc][title]Presentation:[/title][description]Presentation: STE, 0.09 % sodium azide (NaN3) and 0.005 % thimerosal.[/description][/add_desc] [add_desc][title]Storage Conditions:[/title][description]-20 °C (between -15 and -30 °C allowed)[/description][/add_desc] [add_desc][title]Inactivation:[/title][description]Thimerosal and beta propiolactone treatment.
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices and techniques are required at work.[/description][/add_desc] [add_desc][title]Material safety note:[/title][description]This product is sold for research use only. Standard Laboratory Practices should be followed when handling this material.
Product contains sodium azide as a preservative. Although the amount of sodium azide is very small appropriate care must be taken when handling this product.[/description][/add_desc] [add_desc][title]Additional product information:[/title][description] Influenza and Other Acute Respiratory Diseases (ARDs) Assay Notes[/description][/add_desc] [add_desc][title]References:[/title][description] Search Influenza A (H3N2) virus references from PubMud.

See all influenza references.[/description][/add_desc] [add_desc][title]Related Products:[/title][description]See other infectious diseases and veterinary reagents.[/description][/add_desc]

Influenza A (H3N2) virus (strain A/Wisconsin/67/05)

[add_desc][title]Source:[/title][description]Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza A virus, strain A/Wisconsin/67/05.[/description][/add_desc] [add_desc][title]Applications:[/title][description]Serological studies of influenza A virus, immunogen for antibody production.[/description][/add_desc] [add_desc][title]Analysis:[/title][description]Purity > 90 %[/description][/add_desc] [add_desc][title]Purification:[/title][description]Ultracentrifugation with 10 – 40 % sucrose gradient.[/description][/add_desc] [add_desc][title]Presentation:[/title][description]STE, 0.09 % sodium azide (NaN3) and 0.005 % thimerosal.[/description][/add_desc] [add_desc][title]Storage Conditions:[/title][description]-20 °C (between -15 and -30 °C allowed)[/description][/add_desc] [add_desc][title]Inactivation:[/title][description]Thimerosal and beta propiolactone treatment.
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices and techniques are required at work.[/description][/add_desc] [add_desc][title]Material safety note:[/title][description]This product is sold for research use only. Standard Laboratory Practices should be followed when handling this material.
Product contains sodium azide as a preservative. Although the amount of sodium azide is very small appropriate care must be taken when handling this product.[/description][/add_desc] [add_desc][title]Additional product information:[/title][description] Influenza and Other Acute Respiratory Diseases (ARDs) Assay Notes[/description][/add_desc] [add_desc][title]References:[/title][description] Search Influenza A (H3N2) virus references from PubMud.

See all influenza references.[/description][/add_desc] [add_desc][title]Related Products:[/title][description]See other infectious diseases and veterinary reagents.[/description][/add_desc]

Influenza A (H1N1) virus (strain A/New Caledonia/20/99)

[add_desc][title]Source:[/title][description]Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza A virus, strain A/New Caledonia/20/99 IVR 116.[/description][/add_desc] [add_desc][title]Applications:[/title][description]Serological studies of influenza A virus, immunogen for antibody production.Serological studies of influenza A virus, immunogen for antibody production.[/description][/add_desc] [add_desc][title]Analysis:[/title][description]Purity > 90 %[/description][/add_desc] [add_desc][title]Immunological activity:[/title][description]Tested with anti-influenza A monoclonal antibodies ( Cat. # 5-IVAN) in ELISA.[/description][/add_desc] [add_desc][title]Purification:[/title][description]Ultracentrifugation with 10 – 40 % sucrose gradient.[/description][/add_desc] [add_desc][title]Presentation:[/title][description]Presentation: STE, 0.09 % sodium azide (NaN3) and 0.005 % thimerosal.[/description][/add_desc] [add_desc][title]Storage Conditions:[/title][description]-20 °C (between -15 and -30 °C allowed)[/description][/add_desc] [add_desc][title]Inactivation:[/title][description]Thimerosal and beta propiolactone treatment.
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices and techniques are required at work.[/description][/add_desc] [add_desc][title]Material safety note:[/title][description]This product is sold for research use only. Standard Laboratory Practices should be followed when handling this material.
Product contains sodium azide as a preservative. Although the amount of sodium azide is very small appropriate care must be taken when handling this product.[/description][/add_desc] [add_desc][title]Additional product information:[/title][description] Influenza and Other Acute Respiratory Diseases (ARDs) Assay Notes[/description][/add_desc] [add_desc][title]References:[/title][description] Search Influenza A (H1N1) virus references from PubMud.

See all influenza references.[/description][/add_desc] [add_desc][title]Related Products:[/title][description]See other infectious diseases and veterinary reagents.[/description][/add_desc]

Influenza A (H1N1) virus (strain A/Taiwan/1/86)

[add_desc][title]Source:[/title][description]Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza A virus, strain A/Taiwan/1/86.[/description][/add_desc] [add_desc][title]Applications:[/title][description]Serological studies of influenza A virus, immunogen for antibody production.[/description][/add_desc] [add_desc][title]Analysis:[/title][description]Purity > 90 %[/description][/add_desc] [add_desc][title]Immunological activity:[/title][description]Tested with anti-influenza A monoclonal antibodies ( Cat. # 5-IVAN) in ELISA.[/description][/add_desc] [add_desc][title]Purification:[/title][description]Ultracentrifugation with 10 – 40 % sucrose gradient.[/description][/add_desc] [add_desc][title]Presentation:[/title][description]STE, 0.09 % sodium azide (NaN3) and 0.005 % thimerosal.[/description][/add_desc] [add_desc][title]Storage Conditions:[/title][description]-20 °C (between -15 and -30 °C allowed)[/description][/add_desc] [add_desc][title]Other information:[/title][description]Thimerosal and beta propiolactone treatment.
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices and techniques are required at work.[/description][/add_desc] [add_desc][title]Material safety note:[/title][description]This product is sold for research use only. Standard Laboratory Practices should be followed when handling this material.
Product contains sodium azide as a preservative. Although the amount of sodium azide is very small appropriate care must be taken when handling this product.[/description][/add_desc] [add_desc][title]Additional product information:[/title][description] Influenza and Other Acute Respiratory Diseases (ARDs) Assay Notes[/description][/add_desc] [add_desc][title]References:[/title][description] Search Influenza A (H1N1) virus references form PubMud.

See all influenza references.[/description][/add_desc] [add_desc][title]Related Products:[/title][description]See other infectious diseases and veterinary reagents.[/description][/add_desc]

Influenza A (H3N2) virus (strain A/Panama/2007/99)

[add_desc][title]Source:[/title][description]Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza A virus, strain A/Panama/2007/99.[/description][/add_desc] [add_desc][title]Applications:[/title][description]Serological studies of influenza A virus, immunogen for antibody production.[/description][/add_desc] [add_desc][title]Analysis:[/title][description]Purity > 90 %[/description][/add_desc] [add_desc][title]Immunological activity:[/title][description]Tested with anti-influenza A monoclonal antibodies in ELISA.[/description][/add_desc] [add_desc][title]Purification:[/title][description]Ultracentrifugation with 10 – 40 % sucrose gradient.[/description][/add_desc] [add_desc][title]Presentation:[/title][description]STE, 0.09 % sodium azide (NaN3) and 0.005 % thimerosal.[/description][/add_desc] [add_desc][title]Storage Conditions:[/title][description]-20 °C (between -15 and -30 °C allowed)[/description][/add_desc] [add_desc][title]Inactivation:[/title][description]Thimerosal and beta propiolactone treatment.
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices and techniques are required at work.[/description][/add_desc] [add_desc][title]Material safety note:[/title][description]This product is sold for research use only. Standard Laboratory Practices should be followed when handling this material.
Product contains sodium azide as a preservative. Although the amount of sodium azide is very small appropriate care must be taken when handling this product.[/description][/add_desc] [add_desc][title]Additional product information:[/title][description] Influenza and Other Acute Respiratory Diseases (ARDs) Assay Notes[/description][/add_desc] [add_desc][title]References:[/title][description] Search Influenza A (H3N2) virus references from PubMud.

See all influenza references.[/description][/add_desc] [add_desc][title]Related Products:[/title][description]See other infectious diseases and veterinary reagents.[/description][/add_desc]

Influenza A (H1N1) virus (strain A/Solomon Islands/03/06)

[add_desc][title]Source:[/title][description]Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza A virus, strainc A/Solomon Islands/03/06.[/description][/add_desc] [add_desc][title]Applications:[/title][description]Serological studies of influenza A virus, immunogen for antibody production.[/description][/add_desc] [add_desc][title]Analysis:[/title][description]Purity > 90 %[/description][/add_desc] [add_desc][title]Purification:[/title][description]Ultracentrifugation with 10 – 40 % sucrose gradient.[/description][/add_desc] [add_desc][title]Presentation:[/title][description]STE, 0.09 % sodium azide (NaN3) and 0.005 % thimerosal.[/description][/add_desc] [add_desc][title]Storage Conditions:[/title][description]-20 °C (between -15 and -30 °C allowed)[/description][/add_desc] [add_desc][title]Inactivation:[/title][description]Thimerosal and beta propiolactone treatment.
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices and techniques are required at work.[/description][/add_desc] [add_desc][title]Material safety note:[/title][description]This product is sold for research use only. Standard Laboratory Practices should be followed when handling this material.
Product contains sodium azide as a preservative. Although the amount of sodium azide is very small appropriate care must be taken when handling this product.[/description][/add_desc] [add_desc][title]Additional product information:[/title][description] Influenza and Other Acute Respiratory Diseases (ARDs) Assay Notes[/description][/add_desc] [add_desc][title]References:[/title][description] Search Influenza A (H1N1) virus references from PubMud.

See all influenza references.[/description][/add_desc] [add_desc][title]Related Products:[/title][description]See other infectious diseases and veterinary reagents.[/description][/add_desc]

Influenza A (H3N2) virus (strain A/Kiev/301/94 like Johannesburg/33/94)

[add_desc][title]Source:[/title][description]Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza A virus, strain A/Kiev/301/94 like /Johannesburg/33/94.[/description][/add_desc] [add_desc][title]Applications:[/title][description]Serological studies of influenza A virus, immunogen for antibody production.[/description][/add_desc] [add_desc][title]Analysis:[/title][description]Purity > 90 %[/description][/add_desc] [add_desc][title]Immunological activity:[/title][description]Tested with anti-influenza A monoclonal antibodies in ELISA.[/description][/add_desc] [add_desc][title]Purification:[/title][description]Ultracentrifugation with 10 – 40 % sucrose gradient.[/description][/add_desc] [add_desc][title]Presentation:[/title][description]STE, 0.09 % sodium azide (NaN3) and 0.005 % thimerosal.[/description][/add_desc] [add_desc][title]Storage Conditions:[/title][description]-20 °C (between -15 and -30 °C allowed)[/description][/add_desc] [add_desc][title]Inactivation:[/title][description]Thimerosal and beta propiolactone treatment.
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices and techniques are required at work.[/description][/add_desc] [add_desc][title]Material safety note:[/title][description]This product is sold for research use only. Standard Laboratory Practices should be followed when handling this material.
Product contains sodium azide as a preservative. Although the amount of sodium azide is very small appropriate care must be taken when handling this product.[/description][/add_desc] [add_desc][title]Additional product information:[/title][description] Influenza and Other Acute Respiratory Diseases (ARDs) Assay Notes[/description][/add_desc] [add_desc][title]References:[/title][description] Search Influenza A (H3N2) virus references from PubMud.

See all influenza references.[/description][/add_desc] [add_desc][title]Related Products:[/title][description]See other infectious diseases and veterinary reagents.[/description][/add_desc]

Influenza B virus (strain B/Florida/04/06)

[add_desc][title]Source:[/title][description]Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza B virus, strain B/Florida/04/06.[/description][/add_desc] [add_desc][title]Applications:[/title][description]Serological studies of influenza B virus, immunogen for antibody production.[/description][/add_desc] [add_desc][title]Analysis:[/title][description]Purity > 90 %[/description][/add_desc] [add_desc][title]Purification:[/title][description]Ultracentrifugation with 10 – 40 % sucrose gradient.[/description][/add_desc] [add_desc][title]Presentation:[/title][description]Presentation: STE, 0.09 % sodium azide (NaN3) and 0.005 % thimerosal.[/description][/add_desc] [add_desc][title]Inactivation:[/title][description]Thimerosal and beta propiolactone treatment.
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices and techniques are required at work.[/description][/add_desc] [add_desc][title]Storage Conditions:[/title][description]-20 °C (between -15 and -30 °C allowed)[/description][/add_desc] [add_desc][title]Material safety note:[/title][description]This product is sold for research use only. Standard Laboratory Practices should be followed when handling this material.
Product contains sodium azide as a preservative. Although the amount of sodium azide is very small appropriate care must be taken when handling this product.[/description][/add_desc] [add_desc][title]Additional product information:[/title][description] Influenza and Other Acute Respiratory Diseases (ARDs) Assay Notes[/description][/add_desc] [add_desc][title]References:[/title][description] Search Influenza B virus-6 references from PubMud.

See all influenza references.[/description][/add_desc] [add_desc][title]Related Products:[/title][description]See other infectious diseases and veterinary reagents.[/description][/add_desc]

Influenza B virus (strain B/Florida/07/04)

[add_desc][title]Source:[/title][description]Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza B virus, strain B/Florida/07/04.[/description][/add_desc] [add_desc][title]Applications:[/title][description]Serological studies of influenza B virus, immunogen for antibody production.[/description][/add_desc] [add_desc][title]Analysis:[/title][description]Purity > 90 %[/description][/add_desc] [add_desc][title]Purification:[/title][description]Ultracentrifugation with 10 – 40 % sucrose gradient.[/description][/add_desc] [add_desc][title]Presentation:[/title][description]STE, 0.09 % sodium azide (NaN3) and 0.005 % thimerosal.[/description][/add_desc] [add_desc][title]Inactivation:[/title][description]Thimerosal and beta propiolactone treatment.
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices and techniques are required at work.[/description][/add_desc] [add_desc][title]Storage Conditions:[/title][description]-20 °C (between -15 and -30 °C allowed)[/description][/add_desc] [add_desc][title]Material safety note:[/title][description]This product is sold for research use only. Standard Laboratory Practices should be followed when handling this material.
Product contains sodium azide as a preservative. Although the amount of sodium azide is very small appropriate care must be taken when handling this product.[/description][/add_desc] [add_desc][title]Additional product information:[/title][description] Influenza and Other Acute Respiratory Diseases (ARDs) Assay Notes[/description][/add_desc] [add_desc][title]References:[/title][description] Search Influenza B virus-5 references from PubMud.

See all influenza references.[/description][/add_desc] [add_desc][title]Related Products:[/title][description]See other infectious diseases and veterinary reagents.[/description][/add_desc]

Influenza A (H1N1) virus (strain A/Beijing/262/95)

[add_desc][title]Source:[/title][description]Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza A virus, strain A/Beijing/262/95.[/description][/add_desc] [add_desc][title]Applications:[/title][description]Serological studies of influenza A virus, immunogen for antibody production.[/description][/add_desc] [add_desc][title]Analysis:[/title][description]Purity > 90 %[/description][/add_desc] [add_desc][title]Immunological activity:[/title][description]Tested with anti-influenza A monoclonal antibodies ( Cat. # 5-IVAN) in ELISA.[/description][/add_desc] [add_desc][title]Purification:[/title][description]Ultracentrifugation with 10 – 40 % sucrose gradient.[/description][/add_desc] [add_desc][title]Presentation:[/title][description]Presentation: STE, 0.09 % sodium azide (NaN3) and 0.005 % thimerosal.[/description][/add_desc] [add_desc][title]Inactivation:[/title][description]Thimerosal and beta propiolactone treatment.
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices and techniques are required at work.[/description][/add_desc] [add_desc][title]Storage Conditions:[/title][description]-20 °C (between -15 and -30 °C allowed)[/description][/add_desc] [add_desc][title]Material safety note:[/title][description]This product is sold for research use only. Standard Laboratory Practices should be followed when handling this material.
Product contains sodium azide as a preservative. Although the amount of sodium azide is very small appropriate care must be taken when handling this product.[/description][/add_desc] [add_desc][title]Additional product information:[/title][description] Influenza and Other Acute Respiratory Diseases (ARDs) Assay Notes[/description][/add_desc] [add_desc][title]References:[/title][description] Search Influenza A (H1N1) virus references from PubMud.

See all influenza references.[/description][/add_desc] [add_desc][title]Related Products:[/title][description]See other infectious diseases and veterinary reagents.[/description][/add_desc]

Influenza B virus, (strain B/Tokyo/53/99)

[add_desc][title]Source:[/title][description]Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza B virus, strain B/Tokyo/53/99.[/description][/add_desc] [add_desc][title]Applications:[/title][description]Serological studies of influenza B virus, immunogen for antibody production.[/description][/add_desc] [add_desc][title]Analysis:[/title][description]Purity > 90 %[/description][/add_desc] [add_desc][title]Immunological activity:[/title][description]Tested with anti-influenza B monoclonal antibodies ( Cat. # 5-IVB) in ELISA.[/description][/add_desc] [add_desc][title]Purification:[/title][description]Ultracentrifugation with 10 – 40 % sucrose gradient.[/description][/add_desc] [add_desc][title]Presentation:[/title][description]STE, 0.09 % sodium azide (NaN3) and 0.005 % thimerosal.[/description][/add_desc] [add_desc][title]Inactivation:[/title][description]Thimerosal and beta propiolactone treatment.
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices and techniques are required at work.[/description][/add_desc] [add_desc][title]Storage Conditions:[/title][description]-20 °C (between -15 and -30 °C allowed)[/description][/add_desc] [add_desc][title]Material safety note:[/title][description]This product is sold for research use only. Standard Laboratory Practices should be followed when handling this material.
Product contains sodium azide as a preservative. Although the amount of sodium azide is very small appropriate care must be taken when handling this product.[/description][/add_desc] [add_desc][title]Additional product information:[/title][description] Influenza and Other Acute Respiratory Diseases (ARDs) Assay Notes[/description][/add_desc] [add_desc][title]References:[/title][description] Search Influenza B virus-2 references from PubMud.

See all influenza references.[/description][/add_desc] [add_desc][title]Related Products:[/title][description]See other infectious diseases and veterinary reagents.[/description][/add_desc]

Monoclonal mouse anti-Influenza A virus non structural (NS) protein

[add_desc][title]MAbs:[/title][description]4A1, 9F10[/description][/add_desc] [add_desc][title]Specificity:[/title][description]Non structural protein of influenza A virus.[/description][/add_desc] [add_desc][title]MAb Isotypes:[/title][description]IgG2a for MAb 4A1
IgG2b for MAb 9F10[/description][/add_desc] [add_desc][title]Applications:[/title][description]All MAbs can be used in ELISA.[/description][/add_desc] [add_desc][title]Presentation:[/title][description]PBS, pH 7.4, 0.1 % sodium azide (NaN3)[/description][/add_desc] [add_desc][title]Storage Conditions:[/title][description]+ 4 °C[/description][/add_desc] [add_desc][title]Material Safety Note:[/title][description]This product is sold as an antibody preparation for research use only. Standard Laboratory Practices should be followed when handling this material.
Contains sodium azide (0.1 %) as preservative. Although the amount of sodium azide is very small appropriate care must be taken when handling this product.[/description][/add_desc] [add_desc][title]Additional product information:[/title][description] Influenza and Other Acute Respiratory Diseases (ARDs) Assay Notes[/description][/add_desc] [add_desc][title]References:[/title][description] Search Influenza A virus non structural (NS) protein references from PubMed.[/description][/add_desc]

Monoclonal mouse anti-influenza virus type A (haemagglutinin)

[add_desc][title]MAbs:[/title][description]C102
Hybridoma clone C102 has been derived from hybridization of Sp2/0 myeloma cells with spleen cells of Balb/c mice immunized with purified influenza virus type A strain H1N1.[/description][/add_desc] [add_desc][title]Specificity:[/title][description]Influenza virus type A, haemagglutinin H1.[/description][/add_desc] [add_desc][title]MAb Isotypes:[/title][description]IgG1 for MAb C102[/description][/add_desc] [add_desc][title]Applications:[/title][description]Detection and serotyping of influenza virus type A.
MAbs can be used for immunocytochemistry, haemagglutinin inhibition, ELISA and immunofluoresence.[/description][/add_desc] [add_desc][title]Purification:[/title][description]Chromatography on protein G Sepharose[/description][/add_desc] [add_desc][title]Presentation:[/title][description]PBS, pH 7.4, 0.1 % sodium azide (NaN3)[/description][/add_desc] [add_desc][title]Storage Conditions:[/title][description]+ 4 °C[/description][/add_desc] [add_desc][title]Material Safety Note:[/title][description]This product is sold as an antibody preparation for research use only. Standard Laboratory Practices should be followed when handling this material.
Contains sodium azide (0.1 %) as preservative. Although the amount of sodium azide is very small appropriate care must be taken when handling this product.[/description][/add_desc] [add_desc][title]Additional product information:[/title][description] Influenza and Other Acute Respiratory Diseases (ARDs) Assay Notes[/description][/add_desc] [add_desc][title]References:[/title][description] Search Influenza A haemagglutinin references from PubMed.[/description][/add_desc]

Monoclonal mouse anti-Influenza A haemagglutinin H3

[add_desc][title]MAbs:[/title][description]InA227, InA246
Hybridoma clones have been derived from hybridization of Sp2/0 myeloma cells with spleen cells of Balb/c mice immunized with Influenza A/Shangdong/9/93 (strain H3N2) derived from allantoic fluid of 10 days old embryonated eggs.[/description][/add_desc] [add_desc][title]Specificity:[/title][description]Influenza A haemagglutinin H3.[/description][/add_desc] [add_desc][title]MAb Isotypes:[/title][description]IgG1 for MAb InA227
IgG2a for MAb InA246[/description][/add_desc] [add_desc][title]Applications:[/title][description]Influenza A H3 haemagglutinin immunodetection in direct or indirect ELISA.
MAbs InA227 and InA246 detect Influenza A H3 haemagglutinin in Western Blotting.[/description][/add_desc] [add_desc][title]Purification:[/title][description]Chromatography on protein A Sepharose[/description][/add_desc] [add_desc][title]Presentation:[/title][description]PBS, pH 7.4, 0.1 % sodium azide (NaN3)[/description][/add_desc] [add_desc][title]Storage Conditions:[/title][description]+ 4 °C[/description][/add_desc] [add_desc][title]Material Safety Note:[/title][description]This product is sold as an antibody preparation for research use only. Standard Laboratory Practices should be followed when handling this material.
Contains sodium azide (0.1 %) as preservative. Although the amount of sodium azide is very small appropriate care must be taken when handling this product.[/description][/add_desc] [add_desc][title]Additional product information:[/title][description] Influenza and Other Acute Respiratory Diseases (ARDs) Assay Notes[/description][/add_desc] [add_desc][title]References:[/title][description] Search Influenza A haemagglutinin H3 references from PubMed.[/description][/add_desc]

Monoclonal mouse anti-influenza virus B group antigen

[add_desc][title]MAbs:[/title][description]R2/3[/description][/add_desc] [add_desc][title]Specificity:[/title][description]MAbs react with hemaglutinin H5 in hemagluttinin inhibition (HI) test.[/description][/add_desc] [add_desc][title]Applications:[/title][description]Indirect EIA, Western blotting[/description][/add_desc] [add_desc][title]Purification:[/title][description]Chromatography on protein A Sepharose[/description][/add_desc] [add_desc][title]Presentation:[/title][description]PBS, pH 7.4, 0.1 % sodium azide (NaN3)[/description][/add_desc] [add_desc][title]Storage Conditions:[/title][description]+ 4 °C[/description][/add_desc] [add_desc][title]Material Safety Note:[/title][description]This product is sold as an antibody preparation for research use only. Standard Laboratory Practices should be followed when handling this material.
Contains sodium azide (0.1 %) as preservative. Although the amount of sodium azide is very small appropriate care must be taken when handling this product.[/description][/add_desc]

Monoclonal mouse anti-influenza A haemagglutinin H5

[add_desc][title]MAbs:[/title][description] 1C7, 1B4. Hybridoma clones have been derived from hybridization of Sp2/0 myeloma cells with spleen cells of Balb/c mice immunized with purified avian influenza virus, type A (H5N1).[/description][/add_desc] [add_desc][title]Specificity:[/title][description]MAbsreactwithhaemagglutininH5.[/description][/add_desc] [add_desc][title]Mouse Isotypes:[/title][description]1C7, 1B4 – IgG2a[/description][/add_desc] [add_desc][title]Applications:[/title][description]

MAbs 1C7 can be used in haemagglutinin inhibition (HI) test. MAb 1B4 can be used in ELISA.

Recommended pair for sandwich immunoassay (capture – detection): 1B4 – 1C7.

[/description][/add_desc] [add_desc][title]Purification:[/title][description]

Protein G chromatography.

[/description][/add_desc] [add_desc][title]Presentation:[/title][description]

PBS, pH 7.4, 0.09% sodium azide (NaN3).

MAb: Concentration: mg/ml
Lot:  Volume: ml
Expiration date: Amount: mg

[/description][/add_desc]

[add_desc][title]Storage Conditions:[/title][description]

Store @ +4oC (+2 ̊…+8 ̊C allowable).

[/description][/add_desc] [add_desc][title]Material Safety Note:[/title][description]

This product is sold for research use only. Standard Laboratory Practices should be followed when handling this lmaterial. Product contains sodium azide as a preservative. Although the amount of sodium azide is very small, appropriate care must be taken when handling when handling this product.

[/description][/add_desc]

 

Skip to toolbar